BioNTech SE (NASDAQ:BNTX) is one of the Stocks That Will Go To The Moon in 2026. On December 18, BioNTech SE (NASDAQ:BNTX) ...
BioNTech SE ( ($BNTX) ) has provided an update. On December 18, 2025, BioNTech SE announced it had closed its acquisition of CureVac N.V., ...
Despite a series of positive operational updates, BioNTech's stock price remains anchored near its yearly lows. The company ...
Despite trading near its 52-week low and posting a year-to-date loss of approximately 28%, BioNTech stock is attracting significant attention from major fina ...
BioNTech's latest narrative update reflects a slightly higher fair value estimate of about $138, tempered by a modestly increased discount rate of roughly 6.72%, as analysts balance confidence in the ...
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. BioNTech SE ( (BNTX)) has provided an ...
BioNTech SE (NASDAQ:BNTX) reported a narrower loss for the second quarter on Monday. The company posted a second-quarter per-share loss of $1.82 (1.60 euros) on Monday, versus a loss of 3.36 euros ...
Mastering stock investing means understanding key factors like momentum to gauge price trends. In this article, we take a deep dive into BioNTech SE (BNTX) to uncover why momentum analysis is ...
Robeco Institutional Asset Management B.V. cut its stake in shares of BioNTech SE Sponsored ADR (NASDAQ:BNTX – Free Report) by 23.5% in the first quarter, according to the company in its most recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results